Visit
The European Stroke Organisation (ESO) has published new guidelines for prehospital management of suspected stroke patients, and recommendations, in collaboration…
New treatment strategies are gaining attention in epilepsy, where current therapeutic options are ineffective for many. Learn more about the…
A record-breaking study into the relationship between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS) onset has revealed a 32-fold…
Real-world data sets were presented at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),…
Learn more about the major research themes in Parkinson’s disease, discussed at the International Congress of Parkinson’s Disease and Movement…
Insomnia is a common sleep disorder with a prevalence ranging from 5.8–20.0%1 and associated with various comorbidities and major societal…
VJNeurology are excited to bring you the latest updates from the International Headache Congress 2021. Learn more about the highlights…
The results of the VNS-REHAB clinical trial demonstrated significant improvements in upper arm function after the application of vagus nerve…
An overview covering some of the exciting research and scientific advances presented at the 7th European Stroke Organisation Conference (ESOC…
Despite an increase in the number of treatments available for migraine, there is still an unmet need for therapies with…
The results of the Phase III AMBAR trial were presented at the 2021 EAN meeting. Read on to learn more…
Highlights from AAN 2021 in headache and stroke! Learn more about the major clinical trials reported at this years’ meeting.
Discover updates from major clinical trials in myasthenia gravis, Parkinson’s disease & ALS presented at AAN 2021!
Multiple sclerosis (MS) is a long-life condition that affects the brain and spinal cord resulting in impaired vision, limb movement,…
Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin…
